The United Laboratories International Holdings Limited (HKG:3933)
Hong Kong · Delayed Price · Currency is HKD 12.18
-0.20 (-1.62%)
At close: Dec 12, 2025
HKG:3933 Market Cap
HKG:3933 has a market cap or net worth of 24.03 billion as of December 12, 2025. Its market cap has increased by 31.46% in one year.
Market Cap
24.03B
Enterprise Value
19.82B
Revenue
15.45B
Ranking
n/a
PE Ratio
6.59
Stock Price
12.18
Market Cap Chart
Since June 15, 2007, HKG:3933's market cap has increased from 4.33B to 24.03B, an increase of 454.72%. That is a compound annual growth rate of 9.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 24.42B | 8.76% |
| Dec 31, 2024 | 22.46B | 76.32% |
| Dec 29, 2023 | 12.74B | 43.06% |
| Dec 30, 2022 | 8.90B | 11.62% |
| Dec 31, 2021 | 7.98B | -21.20% |
| Dec 31, 2020 | 10.12B | 8.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 274.43B |
| Hansoh Pharmaceutical Group Company | 257.41B |
| JD Health International | 188.25B |
| Innovent Biologics | 143.10B |
| WuXi Biologics | 138.62B |
| Sino Biopharmaceutical | 121.03B |
| Akeso | 107.59B |
| Sichuan Kelun-Biotech Biopharmaceutical | 96.12B |